SCHEMBL7954876

SCHEMBL7954876

Cc1cccc(-c2nc(-c3ccccc3OCCN(C)C)no2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 9/20 0.55
NPC1 O15118 7/20 0.55
RAB9A P51151 6/20 0.55
TP53 P04637 6/20 0.55
ALDH1A1 P00352 5/20 0.55
HSD17B10 Q99714 5/20 0.55
HPGD P15428 4/20 0.55
MEN1 O00255 1/20 0.55
NFKB1 P19838 1/20 0.55
NFKB2 Q00653 1/20 0.55
KMT2A Q03164 1/20 0.55
RELA Q04206 1/20 0.55
HTR7 P34969 2/20 0.52
GRM5 P41594 1/20 0.51
KDM4E B2RXH2 5/20 0.50
TSHR P16473 4/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
NPSR1 Q6W5P4 2/20 0.48
S1PR1 P21453 4/20 0.48
S1PR3 Q99500 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958616 0.91 NPC1 (0.67) SMN1; SMN2NPC1RAB9ATP53ALDH1A1
SCHEMBL7956779 0.89 HTR7 (0.52) SMN1; SMN2NPC1RAB9ATP53ALDH1A1
SCHEMBL5736045 0.88 HTR7 (0.63) SMN1; SMN2NPC1RAB9ATP53ALDH1A1
SCHEMBL7947853 0.88 HTR7 (0.51) SMN1; SMN2NPC1RAB9ATP53ALDH1A1
SCHEMBL7947522 0.88 HTR7 (0.51) SMN1; SMN2NPC1RAB9ATP53ALDH1A1
SCHEMBL7956454 0.87 HTR7 (0.52) SMN1; SMN2NPC1RAB9ATP53ALDH1A1
SCHEMBL7954897 0.84 HTR7 (0.56) SMN1; SMN2NPC1RAB9ATP53ALDH1A1
SCHEMBL7957222 0.84 HTR7 (0.53) SMN1; SMN2NPC1RAB9ATP53ALDH1A1
SCHEMBL7947650 0.82 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ATP53ALDH1A1
SCHEMBL7947658 0.82 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ATP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277872-B1 ANTIISCHEMIC AGENTS; BRAIN DISORDERS BOEHRINGER INGELHEIM KG (DE) 2001-08-21 US disclosed